Affibody

Companies Affibody

News Affibody

• Algeta Signs Exclusive Worldwide License with Affibody for Two Proprietary Molecules for use in New Tumor-targeted Alpha-pharmaceuticals based on Thorium

  Algeta ASA announced that it has entered into an exclusive research, development and commercialization agreement with Affibody to develop tumor-targeting alpha-pharmaceuticals based on thorium-227Under the terms of the agreement, Algeta gains access to two proprietary Affibody® molecules for use in more

• Algeta appoints Lars Abrahmsén as Senior Vice President, Protein Therapeutics

  Algeta ASA announced that Dr. Lars Abrahmsén has been appointed as Senior Vice President, Protein Therapeutics and will take up this new role on 15 November 2010. Dr. Abrahmsén will be responsible for the development of Algeta's Thorium platform and for building and overseeing the preclinical deve more

• Newly Discovered Protein Inhibits the Formation of the Precursor to Alzheimer's Plaques

  As of today, there is no cure or effective treatment of Alzheimer's disease. Swedish researchers have now through their discoveries opened up new possible strategies for potential treatment of the actual cause of the disease. These results have been obtained through a fruitful collaboration between more

Publications Affibody

• Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

  by Magdalena Malm, Nina Kronqvist, Hanna Lindberg, Lindvi Gudmundsdotter, Tarek Bass, Fredrik Y. Frejd, Ingmarie Höidén-Guthenberg, Zohreh Varasteh, Anna Orlova, Vladimir Tolmachev, Stefan Ståhl, John Löfblom The HER3 receptor is implicated in the progression of various cancers as well as in resi more

• Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody

  by Kristian Sexton, Kenneth Tichauer, Kimberley S. Samkoe, Jason Gunn, P. Jack Hoopes, Brian W. Pogue Object Fluorescence imaging has the potential to significantly improve neurosurgical resection of oncologic lesions through improved differentiation between normal and cancerous tissue at the tum more

• Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer

  Molecular imagings of hEGF receptor 2 (HER2) using radiolabeled tracers has the potential to determine the extent of HER2-positive disease and could be of great clinical value. HER2 overexpression affects 20–25% of breast cancer patients, conferring a worse prognosis. HER2 status determines choice a more

Market studies Affibody

• World Biological Drugs Market 2011-2021

  Do you want to find market prospects for products and companies in the biological drugs industry? Our new report shows you biopharma revenue forecasts for 2011 to 2021. We provide original research, data and opinions to benefit your work now. What revenues will biopharmaceutical markets achieve fro more

Websites Affibody